OXB.L
Oxford BioMedica PLC
Price:
320
GBP
Volume:
159,159
United Kingdom | Biotechnology
OXB.L Gross Margin
As of 2025-05-24, the Gross Margin of Oxford Biomedica PLC (OXB.L) is 41.2%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
OXB.L Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | 41.2% |
| 2023-12-31 | 44.4% |
| 2022-12-31 | 49.4% |
| 2021-12-31 | 57.9% |
| 2020-12-31 | 52.5% |
| 2019-12-31 | 44.2% |
| 2018-12-31 | 65.9% |
| 2017-12-31 | 50.9% |
| 2016-12-31 | 57.4% |
| 2015-12-31 | 63.3% |
OXB.L Gross Margin - Peers Comparison